{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:34:54Z","timestamp":1777336494763,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100221"],"award-info":[{"award-number":["81100221"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30832"],"award-info":[{"award-number":["2022JJ30832"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12012-026-10116-9","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T02:43:18Z","timestamp":1776048198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydroxysafflor Yellow A Attenuates Sepsis-Induced Cardiac Dysfunction by Inhibiting Ferroptosis via Activation of Thioredoxin"],"prefix":"10.1007","volume":"26","author":[{"given":"Yanke","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"1","key":"10116_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"M GIAMARELLOS-BOURBOULIS E J, ASCHENB","year":"2024","unstructured":"GIAMARELLOS-BOURBOULIS E J, ASCHENBRENNER A C, BAUER, M., et al. (2024). The pathophysiology of sepsis and precision-medicine-based immunotherapy [J]. Nature Immunology, 25(1), 19\u201328. https:\/\/doi.org\/10.1038\/s41590-023-01660-5","journal-title":"Nature Immunology"},{"key":"10116_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/DDDT.S506537","volume":"19","author":"Y JIN","year":"2025","unstructured":"JIN, Y., FLEISHMAN J S, MA, Y., et al. (2025). NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury [J]. Drug Design, Development And Therapy, 19, 1025\u20131041. https:\/\/doi.org\/10.2147\/DDDT.S506537","journal-title":"Drug Design, Development And Therapy"},{"issue":"2","key":"10116_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00204-024-03916-x","volume":"99","author":"H LIU","year":"2025","unstructured":"LIU, H., XU, C., HU, Q., et al. (2025). Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications [J]. Archives Of Toxicology, 99(2), 467\u2013480. https:\/\/doi.org\/10.1007\/s00204-024-03916-x","journal-title":"Archives Of Toxicology"},{"issue":"17","key":"10116_CR4","doi-asserted-by":"publisher","first-page":"e37940","DOI":"10.1097\/MD.0000000000037940","volume":"103","author":"H HIRAIWA","year":"2024","unstructured":"HIRAIWA, H., KASUGAI, D., OKUMURA, T., et al. (2024). Clinical implications of septic cardiomyopathy: A narrative review [J]. Medicine (Baltimore), 103(17), e37940. https:\/\/doi.org\/10.1097\/MD.0000000000037940","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10116_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"JA DIXON S J, OLZMANN","year":"2024","unstructured":"DIXON S J, OLZMANN, J. A. (2024). The cell biology of ferroptosis [J]. Nature Reviews Molecular Cell Biology, 25(6), 424\u2013442. https:\/\/doi.org\/10.1038\/s41580-024-00703-5","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"12","key":"10116_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"SJ POPE L E, DIXON","year":"2023","unstructured":"POPE L E, DIXON, S. J. (2023). Regulation of ferroptosis by lipid metabolism [J]. Trends In Cell Biology, 33(12), 1077\u20131087. https:\/\/doi.org\/10.1016\/j.tcb.2023.05.003","journal-title":"Trends In Cell Biology"},{"issue":"1","key":"10116_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10565-024-09853-w","volume":"40","author":"W FANG","year":"2024","unstructured":"FANG, W., XIE, S., & DENG, W. (2024). Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future [J]. Cell Biology And Toxicology, 40(1), 17. https:\/\/doi.org\/10.1007\/s10565-024-09853-w","journal-title":"Cell Biology And Toxicology"},{"key":"10116_CR8","doi-asserted-by":"publisher","first-page":"115438","DOI":"10.1016\/j.ejmech.2023.115438","volume":"257","author":"L HUO","year":"2023","unstructured":"HUO, L., LIU, C., YUAN, Y., et al. (2023). Pharmacological inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage [J]. European Journal Of Medicinal Chemistry, 257, 115438. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115438","journal-title":"European Journal Of Medicinal Chemistry"},{"issue":"1","key":"10116_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X FANG","year":"2023","unstructured":"FANG, X., ARDEHALI, H., MIN, J., et al. (2023). The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease [J]. Nature Reviews. Cardiology, 20(1), 7\u201323. https:\/\/doi.org\/10.1038\/s41569-022-00735-4","journal-title":"Nature Reviews. Cardiology"},{"issue":"8","key":"10116_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","volume":"44","author":"SHENG S Y","year":"2023","unstructured":"SHENG S Y, LI J M, HU X Y, et al. (2023). Regulated cell death pathways in cardiomyopathy [J]. Acta Pharmacologica Sinica, 44(8), 1521\u20131535. https:\/\/doi.org\/10.1038\/s41401-023-01068-9","journal-title":"Acta Pharmacologica Sinica"},{"key":"10116_CR11","doi-asserted-by":"publisher","first-page":"102629DOI","DOI":"10.1016\/j.arr.2024.102629","volume":"104","author":"L ZHU","year":"2025","unstructured":"ZHU, L., LIU, Y., WANG, K., et al. (2025). Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implications [J]. Ageing Research Reviews, 104, 102629DOI. https:\/\/doi.org\/10.1016\/j.arr.2024.102629","journal-title":"Ageing Research Reviews"},{"key":"10116_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bioactmat.2022.12.026","volume":"24","author":"C LIU","year":"2023","unstructured":"LIU, C., ZOU, Q., TANG, H., et al. (2023). Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation [J]. Bioact Mater, 24, 313\u2013321. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.12.026","journal-title":"Bioact Mater"},{"key":"10116_CR13","doi-asserted-by":"publisher","first-page":"107056DOI","DOI":"10.1016\/j.phrs.2023.107056","volume":"200","author":"R LIU","year":"2024","unstructured":"LIU, R., LI, F., HAO, S., et al. (2024). Low-dose Olaparib improves septic cardiac function by reducing ferroptosis via accelerated mitophagy flux [J]. Pharmacological Research, 200, 107056DOI. https:\/\/doi.org\/10.1016\/j.phrs.2023.107056","journal-title":"Pharmacological Research"},{"issue":"1","key":"10116_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","volume":"5","author":"D LI","year":"2020","unstructured":"LI, D., & LI, Y. (2020). The interaction between ferroptosis and lipid metabolism in cancer [J]. Signal Transduct Target Ther, 5(1), 108. https:\/\/doi.org\/10.1038\/s41392-020-00216-5","journal-title":"Signal Transduct Target Ther"},{"key":"10116_CR15","doi-asserted-by":"publisher","first-page":"1495393","DOI":"10.3389\/fphar.2024.1495393","volume":"15","author":"Y WANG","year":"2024","unstructured":"WANG, Y., AN, J., ZHOU, J., et al. (2024). Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect [J]. Frontiers In Pharmacology, 15, 1495393. https:\/\/doi.org\/10.3389\/fphar.2024.1495393","journal-title":"Frontiers In Pharmacology"},{"key":"10116_CR16","doi-asserted-by":"publisher","first-page":"105224","DOI":"10.1016\/j.phrs.2020.105224","volume":"163","author":"HE Y Q","year":"2021","unstructured":"HE Y Q, ZHOU C C, YU L Y, et al. (2021). Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms [J]. Pharmacological Research, 163, 105224. https:\/\/doi.org\/10.1016\/j.phrs.2020.105224","journal-title":"Pharmacological Research"},{"key":"10116_CR17","doi-asserted-by":"publisher","first-page":"153694","DOI":"10.1016\/j.phymed.2021.153694","volume":"91","author":"X XUE","year":"2021","unstructured":"XUE, X., DENG, Y., WANG, J., et al. (2021). Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis [J]. Phytomedicine, 91, 153694. https:\/\/doi.org\/10.1016\/j.phymed.2021.153694","journal-title":"Phytomedicine"},{"key":"10116_CR18","doi-asserted-by":"publisher","first-page":"579332","DOI":"10.3389\/fphar.2020.579332","volume":"11","author":"F ZHAO","year":"2020","unstructured":"ZHAO, F., WANG, P., JIAO, Y., et al. (2020). Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects [J]. Frontiers In Pharmacology, 11, 579332. https:\/\/doi.org\/10.3389\/fphar.2020.579332","journal-title":"Frontiers In Pharmacology"},{"issue":"1","key":"10116_CR19","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/s41467-025-59774-3","volume":"16","author":"G WANG Z L, WANG H T, CHANG","year":"2025","unstructured":"WANG Z L, WANG H T, CHANG, G., et al. (2025). Elucidation of the biosynthetic pathway of hydroxysafflor yellow A [J]. Nature Communications, 16(1), 4489. https:\/\/doi.org\/10.1038\/s41467-025-59774-3","journal-title":"Nature Communications"},{"issue":"5","key":"10116_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41401-023-01224-1","volume":"45","author":"C CHENG","year":"2024","unstructured":"CHENG, C., REN, C., LI M, Z, et al. (2024). Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation [J]. Acta Pharmacologica Sinica, 45(5), 1077\u20131092. https:\/\/doi.org\/10.1038\/s41401-023-01224-1","journal-title":"Acta Pharmacologica Sinica"},{"key":"10116_CR21","doi-asserted-by":"publisher","first-page":"614024","DOI":"10.3389\/fphar.2020.614024","volume":"11","author":"WANG X T","year":"2020","unstructured":"WANG X T, PENG Z, AN Y Y, et al. (2020). Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production [J]. Frontiers In Pharmacology, 11, 614024. https:\/\/doi.org\/10.3389\/fphar.2020.614024","journal-title":"Frontiers In Pharmacology"},{"key":"10116_CR22","doi-asserted-by":"publisher","unstructured":"ALOKDA, A., & VAN RAAMSDONK, J. M. (2023). Evolutionarily Conserved Role of Thioredoxin Systems in Determining Longevity [J]. Antioxidants (Basel), 12(4). https:\/\/doi.org\/10.3390\/antiox12040944","DOI":"10.3390\/antiox12040944"},{"issue":"2","key":"10116_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/cphy.c140042","volume":"5","author":"YOSHIOKA J","year":"2015","unstructured":"YOSHIOKA J. (2015). Thioredoxin superfamily and its effects on cardiac physiology and pathology [J]. Compr Physiol, 5(2), 513\u2013530. https:\/\/doi.org\/10.1002\/cphy.c140042","journal-title":"Compr Physiol"},{"issue":"11\u201312","key":"10116_CR24","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1089\/ars.2006.8.2153","volume":"8","author":"KUSTER G M","year":"2006","unstructured":"KUSTER G M, SIWIK D A, PIMENTEL D R, et al. (2006). Role of reversible, thioredoxin-sensitive oxidative protein modifications in cardiac myocytes [J]. Antioxidants & Redox Signaling, 8(11\u201312), 2153\u20132159. https:\/\/doi.org\/10.1089\/ars.2006.8.2153","journal-title":"Antioxidants & Redox Signaling"},{"key":"10116_CR25","doi-asserted-by":"publisher","first-page":"103277","DOI":"10.1016\/j.redox.2024.103277","volume":"75","author":"D BAI","year":"2024","unstructured":"BAI, D., ZHOU, C., DU, J., et al. (2024). TrxR1 is involved in the activation of Caspase-11 by regulating the oxidative-reductive status of Trx-1 [J]. Redox Biology, 75, 103277. https:\/\/doi.org\/10.1016\/j.redox.2024.103277","journal-title":"Redox Biology"},{"key":"10116_CR26","doi-asserted-by":"publisher","first-page":"14125","DOI":"10.2147\/ijn.S497081","volume":"19","author":"PQ GUO N K, SI L N, LI","year":"2024","unstructured":"GUO N K, SI L N, LI, P. Q., et al. (2024). Nano Acacetin Mitigates Intestinal Mucosal Injury in Sepsis Rats by Protecting Mitochondrial Function and Regulating TRX1 to Inhibit the NLRP3 Pyroptosis Pathway [J]. Int J Nanomedicine, 19, 14125\u201314141. https:\/\/doi.org\/10.2147\/ijn.S497081","journal-title":"Int J Nanomedicine"},{"key":"10116_CR27","doi-asserted-by":"publisher","unstructured":"ZHANG, J., LI, X., ZHAO, Z. (2023). Thioredoxin Signaling Pathways in Cancer [J]. Antioxid Redox Signal, 38(4\u20136): 403\u2009\u2013\u200924.https:\/\/doi.org\/10.1089\/ars.2022.0074","DOI":"10.1089\/ars.2022.0074"},{"key":"10116_CR28","doi-asserted-by":"publisher","first-page":"111004","DOI":"10.1016\/j.cbi.2024.111004","volume":"395","author":"MS HSIEH","year":"2024","unstructured":"HSIEH, M. S., LING H H, SETIAWAN S A, et al. (2024). Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer [J]. Chem Biol Interact, 395, 111004. https:\/\/doi.org\/10.1016\/j.cbi.2024.111004","journal-title":"Chem Biol Interact"},{"key":"10116_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci190215","author":"LIN C C","year":"2025","unstructured":"LIN C C, LIN Y T, CHEN S Y, et al. (2025). Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase [J]. J Clin Invest. https:\/\/doi.org\/10.1172\/jci190215","journal-title":"J Clin Invest"},{"key":"10116_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa971","author":"S KIM","year":"2021","unstructured":"KIM, S., CHEN, J., CHENG, T. (2021). PubChem in 2021: new data content and improved web interfaces [J]. Nucleic Acids Research, 49(D1): D1388\u2013d95.DOI:https:\/\/doi.org\/10.1093\/nar\/gkaa971."},{"key":"10116_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz382","author":"A DAINA","year":"2019","unstructured":"DAINA, A., & MICHIELIN O, Z. O. E. T. E. V. (2019). SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules [J]. Nucleic Acids Research, 47(W1): W357\u2013w64.DOI:https:\/\/doi.org\/10.1093\/nar\/gkz382."},{"issue":"W1","key":"10116_CR32","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X WANG","year":"2017","unstructured":"WANG, X., SHEN, Y., WANG, S., et al. (2017). PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database [J]. Nucleic Acids Research, 45(W1), W356\u2013w60. https:\/\/doi.org\/10.1093\/nar\/gkx374","journal-title":"Nucleic Acids Research"},{"key":"10116_CR33","doi-asserted-by":"publisher","unstructured":"SAFRAN, M., DALAH, I., ALEXANDER, J. (2010). GeneCards Version 3: the human gene integrator [J]. Database (Oxford), 2010: baq020.https:\/\/doi.org\/10.1093\/database\/baq020","DOI":"10.1093\/database\/baq020"},{"issue":"6","key":"10116_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/mutage\/geab039","volume":"36","author":"S AVLASEVICH","year":"2021","unstructured":"AVLASEVICH, S., PELLEGRIN, T., GODSE, M., et al. (2021). Biomarkers of DNA damage response improve in vitro micronucleus assays by revealing genotoxic mode of action and reducing the occurrence of irrelevant positive results [J]. Mutagenesis, 36(6), 407\u2013418. https:\/\/doi.org\/10.1093\/mutage\/geab039","journal-title":"Mutagenesis"},{"issue":"Database issue","key":"10116_CR35","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS AMBERGER","year":"2015","unstructured":"AMBERGER, J. S., BOCCHINI C A, SCHIETTECATTE, F., et al. (2015). OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders [J]. Nucleic Acids Research, 43(Database issue), D789\u2013D798. https:\/\/doi.org\/10.1093\/nar\/gku1205","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"10116_CR36","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"UniProt","year":"2021","unstructured":"UniProt. (2021). the universal protein knowledgebase in 2021 [J]. Nucleic Acids Research, 49(D1), D480\u2013d9. https:\/\/doi.org\/10.1093\/nar\/gkaa1100","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"10116_CR37","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D SZKLARCZYK","year":"2023","unstructured":"SZKLARCZYK, D., KIRSCH, R., KOUTROULI, M., et al. (2023). The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest [J]. Nucleic Acids Research, 51(D1), D638\u2013d46. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10116_CR38","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"JR DENNIS G","year":"2003","unstructured":"DENNIS G, J. R., SHERMAN B T, HOSACK D A, et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery [J]. Genome Biology, 4(5), P3.","journal-title":"Genome Biology"},{"issue":"1","key":"10116_CR39","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y ZHOU","year":"2019","unstructured":"ZHOU, Y., & ZHOU, B. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets [J]. Nature Communications, 10(1), 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nature Communications"},{"key":"10116_CR40","doi-asserted-by":"publisher","unstructured":"ZHOU, N. (2020). BAO J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations [J]. Database (Oxford), 2020.https:\/\/doi.org\/10.1093\/database\/baaa021","DOI":"10.1093\/database\/baaa021"},{"key":"10116_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1091","author":"R BURLEY S K, BHATT","year":"2025","unstructured":"BURLEY S K, BHATT, R., BHIKADIYA, C. (2025). Updated resources for exploring experimentally-determined PDB structures and Computed Structure Models at the RCSB Protein Data Bank [J]. Nucleic Acids Research, 53(D1): D564\u2013d74.DOI:https:\/\/doi.org\/10.1093\/nar\/gkae1091."},{"key":"10116_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2024.11.007","volume":"226","author":"S HE","year":"2025","unstructured":"HE, S., YE, H., WANG, Q., et al. (2025). Ginsenoside Rb1 targets to HO-1 to improve sepsis by inhibiting ferroptosis [J]. Free Radical Biology And Medicine, 226, 13\u201328. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.11.007","journal-title":"Free Radical Biology And Medicine"},{"issue":"6","key":"10116_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3892\/etm.2022.11677","volume":"24","author":"Y WANG","year":"2022","unstructured":"WANG, Y., HAN, K., LI, Z., et al. (2022). Protective effect of hydroxysafflor yellow A on renal ischemia\u2013-reperfusion injury by targeting the Akt\u2013Nrf2 axis in mice [J]. Exp Ther Med, 24(6), 741. https:\/\/doi.org\/10.3892\/etm.2022.11677","journal-title":"Exp Ther Med"},{"key":"10116_CR44","doi-asserted-by":"publisher","first-page":"613DOI","DOI":"10.3389\/fphar.2017.00613","volume":"8","author":"J WANG","year":"2017","unstructured":"WANG, J., & WANG, P. (2017). Hydroxysafflor Yellow A Attenuates the Apoptosis of Peripheral Blood CD4(+) T Lymphocytes in a Murine Model of Sepsis [J]. Frontiers In Pharmacology, 8, 613DOI. https:\/\/doi.org\/10.3389\/fphar.2017.00613","journal-title":"Frontiers In Pharmacology"},{"issue":"8","key":"10116_CR45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"ABDUL-AZIZ M H","year":"2024","unstructured":"ABDUL-AZIZ M H, HAMMOND N E, BRETT S J, et al. (2024). Prolonged vs Intermittent Infusions of \u03b2-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis [J]. Jama, 332(8), 638\u2013648. https:\/\/doi.org\/10.1001\/jama.2024.9803","journal-title":"Jama"},{"issue":"4","key":"10116_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s2213-2600(23)00330-2","volume":"12","author":"S CAJANDER","year":"2024","unstructured":"CAJANDER, S., KOX, M., SCICLUNA B P, et al. (2024). Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine [J]. Lancet Respir Med, 12(4), 305\u2013322. https:\/\/doi.org\/10.1016\/s2213-2600(23)00330-2","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10116_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13054-024-05069-w","volume":"28","author":"D HU","year":"2024","unstructured":"HU, D., SHEEJA PRABHAKARAN H, ZHANG Y Y, et al. (2024). Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives [J]. Critical Care, 28(1), 292. https:\/\/doi.org\/10.1186\/s13054-024-05069-w","journal-title":"Critical Care"},{"key":"10116_CR48","doi-asserted-by":"publisher","first-page":"1555103","DOI":"10.3389\/fmed.2025.1555103","volume":"12","author":"P GUO","year":"2025","unstructured":"GUO, P., & TAO, X. U. E. L. (2025). Prognostic analysis of sepsis-induced myocardial injury patients using propensity score matching and doubly robust analysis with machine learning-based risk prediction model development [J]. Front Med (Lausanne), 12, 1555103. https:\/\/doi.org\/10.3389\/fmed.2025.1555103","journal-title":"Front Med (Lausanne)"},{"key":"10116_CR49","doi-asserted-by":"publisher","first-page":"112790","DOI":"10.1016\/j.jep.2020.112790","volume":"256","author":"J YANG","year":"2020","unstructured":"YANG, J., WANG, R., CHENG, X., et al. (2020). The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells [J]. Journal Of Ethnopharmacology, 256, 112790. https:\/\/doi.org\/10.1016\/j.jep.2020.112790","journal-title":"Journal Of Ethnopharmacology"},{"issue":"5","key":"10116_CR50","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1111\/jcmm.13552","volume":"22","author":"J ZOU","year":"2018","unstructured":"ZOU, J., WANG, N., LIU, M., et al. (2018). Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9 [J]. Journal Of Cellular And Molecular Medicine, 22(5), 2692\u20132705. https:\/\/doi.org\/10.1111\/jcmm.13552","journal-title":"Journal Of Cellular And Molecular Medicine"},{"key":"10116_CR51","doi-asserted-by":"publisher","first-page":"112511DOI","DOI":"10.1016\/j.colsurfb.2022.112511","volume":"215","author":"Q TANG","year":"2022","unstructured":"TANG, Q., YI, Y., CHEN, Y., et al. (2022). A green and highly efficient method to deliver hydrophilic polyphenols of Salvia miltiorrhiza and Carthamus tinctorius for enhanced anti-atherosclerotic effect via metal-phenolic network [J]. Colloids And Surfaces. B, Biointerfaces, 215, 112511DOI. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112511","journal-title":"Colloids And Surfaces. B, Biointerfaces"},{"issue":"1","key":"10116_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cpdd.1487","volume":"14","author":"X ZHAO","year":"2025","unstructured":"ZHAO, X., GU, S., WANG, X., et al. (2025). The Safety, Tolerability, and Pharmacokinetics of Active Ingredients From Hydroxysafflor Yellow A in Healthy Chinese Volunteers [J]. Clin Pharmacol Drug Dev, 14(1), 79\u201386. https:\/\/doi.org\/10.1002\/cpdd.1487","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10116_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jep.2014.12.068","volume":"162","author":"J LI C Y, YIN J G, ZHANG","year":"2015","unstructured":"LI C Y, YIN J G, ZHANG, J., et al. (2015). Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers [J]. Journal Of Ethnopharmacology, 162, 225\u2013230. https:\/\/doi.org\/10.1016\/j.jep.2014.12.068","journal-title":"Journal Of Ethnopharmacology"},{"issue":"6","key":"10116_CR54","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11655-020-3094-7","volume":"26","author":"HU M Z","year":"2020","unstructured":"HU M Z, ZHOU Z Y, ZHOU Z Y, et al. (2020). Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial [J]. Chinese Journal Of Integrative Medicine, 26(6), 420\u2013427. https:\/\/doi.org\/10.1007\/s11655-020-3094-7","journal-title":"Chinese Journal Of Integrative Medicine"},{"issue":"2","key":"10116_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.intimp.2014.10.018","volume":"23","author":"Y LIU Y L, LIU Y J, LIU","year":"2014","unstructured":"LIU Y L, LIU Y J, LIU, Y., et al. (2014). Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways [J]. International Immunopharmacology, 23(2), 649\u2013657. https:\/\/doi.org\/10.1016\/j.intimp.2014.10.018","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10116_CR56","doi-asserted-by":"publisher","first-page":"25861","DOI":"10.1038\/s41598-025-11545-2","volume":"15","author":"B PAN","year":"2025","unstructured":"PAN, B., CHEN, F., SHEN, S., et al. (2025). Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2\/STAT1 pathway in sepsis [J]. Scientific Reports, 15(1), 25861. https:\/\/doi.org\/10.1038\/s41598-025-11545-2","journal-title":"Scientific Reports"},{"key":"10116_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2023.10.011","volume":"63","author":"C JIANG","year":"2024","unstructured":"JIANG, C., SHI, Q., YANG, J., et al. (2024). Ceria nanozyme coordination with curcumin for treatment of sepsis-induced cardiac injury by inhibiting ferroptosis and inflammation [J]. Journal Of Advanced Research, 63, 159\u2013170. https:\/\/doi.org\/10.1016\/j.jare.2023.10.011","journal-title":"Journal Of Advanced Research"},{"key":"10116_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.yjmcc.2024.05.007","volume":"192","author":"Y HUANG","year":"2024","unstructured":"HUANG, Y., LI, L., LI, Y., et al. (2024). Knockdown of LncRNA Lcn2-204 alleviates sepsis-induced myocardial injury by regulation of iron overload and ferroptosis [J]. Journal Of Molecular And Cellular Cardiology, 192, 79\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.05.007","journal-title":"Journal Of Molecular And Cellular Cardiology"},{"key":"10116_CR59","doi-asserted-by":"publisher","unstructured":"GE, C., PENG, Y., LI, J., et al. (2023). Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia\/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1\u03b1\/SLC7A11\/GPX4 Signaling Pathway [J]. Nutrients, 15(15). https:\/\/doi.org\/10.3390\/nu15153411","DOI":"10.3390\/nu15153411"},{"issue":"1","key":"10116_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/13880209.2023.2225543","volume":"61","author":"J RONG","year":"2023","unstructured":"RONG, J., LI, C., ZHANG, Q., et al. (2023). Hydroxysafflor yellow A inhibits endothelial cell ferroptosis in diabetic atherosclerosis mice by regulating miR-429\/SLC7A11 [J]. Pharmaceutical Biology, 61(1), 404\u2013415. https:\/\/doi.org\/10.1080\/13880209.2023.2225543","journal-title":"Pharmaceutical Biology"},{"key":"10116_CR61","doi-asserted-by":"publisher","first-page":"106316","DOI":"10.1016\/j.intimp.2020.106316","volume":"82","author":"M YE J X, WANG","year":"2020","unstructured":"YE J X, WANG, M., WANG R Y, et al. (2020). Hydroxysafflor yellow A inhibits hypoxia\/reoxygenation-induced cardiomyocyte injury via regulating the AMPK\/NLRP3 inflammasome pathway [J]. International Immunopharmacology, 82, 106316. https:\/\/doi.org\/10.1016\/j.intimp.2020.106316","journal-title":"International Immunopharmacology"},{"key":"10116_CR62","doi-asserted-by":"publisher","unstructured":"WU, P., ZHANG, X. (2023). DUAN D,. Organelle-Specific Mechanisms in Crosstalk between Apoptosis and Ferroptosis [J]. Oxid Med Cell Longev, 2023: 3400147.https:\/\/doi.org\/10.1155\/2023\/3400147","DOI":"10.1155\/2023\/3400147"},{"key":"10116_CR63","doi-asserted-by":"publisher","unstructured":"OBERACKER, T., KRAFT, L., SCHANZ, M., et al. (2023). The Importance of Thioredoxin-1 in Health and Disease [J]. Antioxidants (Basel), 12(5). https:\/\/doi.org\/10.3390\/antiox12051078","DOI":"10.3390\/antiox12051078"},{"key":"10116_CR64","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.redox.2024.103032","volume":"70","author":"B YANG","year":"2024","unstructured":"YANG, B., LIN, Y., HUANG, Y., et al. (2024). Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases [J]. Redox Biology, 70, 103032. https:\/\/doi.org\/10.1016\/j.redox.2024.103032","journal-title":"Redox Biology"},{"issue":"2","key":"10116_CR65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00134-009-1640-z","volume":"36","author":"PINGLEV LEAVER S K, MACCALLUM N S","year":"2010","unstructured":"LEAVER S K, MACCALLUM N S, P. I. N. G. L. E. V., et al. (2010). Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor [J]. Intensive Care Medicine, 36(2), 336\u2013341. https:\/\/doi.org\/10.1007\/s00134-009-1640-z","journal-title":"Intensive Care Medicine"},{"key":"10116_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jss.2017.06.062","volume":"220","author":"RL WILSON","year":"2017","unstructured":"WILSON, R. L., SELVARAJU, V., LAKSHMANAN, R., et al. (2017). Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice [J]. Journal Of Surgical Research, 220, 68\u201378. https:\/\/doi.org\/10.1016\/j.jss.2017.06.062","journal-title":"Journal Of Surgical Research"},{"key":"10116_CR67","doi-asserted-by":"publisher","unstructured":"LIN C C, LIN Y T, CHEN S Y, et al. (2025). Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase [J]. J Clin Invest, 135(19). https:\/\/doi.org\/10.1172\/jci190215","DOI":"10.1172\/jci190215"},{"issue":"3","key":"10116_CR68","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/cvr\/cvz152","volume":"116","author":"C GAO","year":"2020","unstructured":"GAO, C., WANG, R., LI, B., et al. (2020). TXNIP\/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia\/reperfusion injury in mice [J]. Cardiovasc Res, 116(3), 645\u2013657. https:\/\/doi.org\/10.1093\/cvr\/cvz152","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10116_CR69","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1038\/s41467-025-63687-6","volume":"16","author":"G BI","year":"2025","unstructured":"BI, G., LIANG, J., BIAN, Y., et al. (2025). Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC [J]. Nature Communications, 16(1), 8181. https:\/\/doi.org\/10.1038\/s41467-025-63687-6","journal-title":"Nature Communications"},{"key":"10116_CR70","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.2147\/idr.S528964","volume":"18","author":"Q CHEN","year":"2025","unstructured":"CHEN, Q., XU, C., FEI, J., et al. (2025). Hydroxysafflor Yellow A Mitigates Sepsis-Induced Pulmonary and Intestinal Injury by Inhibiting TP53 Mediated Ferroptosis [J]. Infect Drug Resist, 18, 6427\u20136450. https:\/\/doi.org\/10.2147\/idr.S528964","journal-title":"Infect Drug Resist"},{"issue":"Pt 1","key":"10116_CR71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2022.10.268","volume":"193","author":"Y YU","year":"2022","unstructured":"YU, Y., WU, T., LU, Y., et al. (2022). Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling [J]. Free Radical Biology And Medicine, 193(Pt 1), 108\u2013121. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.10.268","journal-title":"Free Radical Biology And Medicine"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10116-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:37:08Z","timestamp":1777333028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-026-10116-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10116"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10116-9","relation":{"references":[{"id-type":"doi","id":"10.1093\/nar\/gkaa971","asserted-by":"subject"},{"id-type":"doi","id":"10.1093\/nar\/gkz382","asserted-by":"subject"},{"id-type":"doi","id":"10.1093\/nar\/gkae1091","asserted-by":"subject"}]},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"43"}}